Priyadarshini Balasubramanian

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Yale University(Current)

University of Würzburg

Lunenfeld-Tanenbaum Research Institute

Boehringer Ingelheim (Norway)

Boehringer Ingelheim (Germany)

Priyadarshini Balasubramanian is an author at Yale University specializing in medicine, small-molecule glp-1 receptor agonists, and severe hypoglycemia management.

ORCID

Publications per year

2019–2023

Publications

Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?

Priyadarshini Balasubramanian, Christoph Wanner, João Pedro Ferreira et al. · The Journal of Clinical Endocrinology & Metabolism · 2022 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Multidisciplinary strategies to treat severe hypoglycemia in hospitalized patients with diabetes mellitus reduce inpatient mortality rate: Experience from an academic community hospital

Deepak K. Kadayakkara, Priyadarshini Balasubramanian, Katherine Araque et al. · PLoS ONE · 2019 · 19 citations · Full text

Medicine, Internal Medicine, Diabetology +16

Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials

Priyadarshini Balasubramanian, Walter N. Kernan, Kevin N. Sheth et al. · Stroke · 2023 · 11 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

1–3 of 3